Featured Research

from universities, journals, and other organizations

Vulnerable Plaque May Be Easier To Detect Through New Imaging Technology

Date:
October 15, 2008
Source:
Cardiovascular Research Foundation
Summary:
Research results indicate that optical coherence tomography, a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries.

Research results indicate that optical coherence tomography (OCT), a newly evolving imaging method, may be the best tool available to detect vulnerable plaque in coronary arteries.

Vulnerable plaque (VP) has been identified as a possible cause of sudden cardiac death, most of which occurs in patients with no history of heart disease. Vulnerable plaque is different from the fibrotic, calcified plaque that grows gradually until a lesion completely occludes an artery. VP is susceptible to sudden rupture, swiftly forming a clot that blocks the flow of blood through a coronary artery, causing a heart attack.

VP consists of an underlying lipid-rich core covered by a thin fibrous cap. This tissue composition has been very difficult to visualize – a crucial first step to diagnosing and treating the condition.

Now, a team of researchers at Ajou University School of Medicine in Suwon, Korea, are reporting that OCT provides superior contrast and resolution in imaging the components of plaque in coronary arteries versus other methods including intravascular ultrasound (IVUS) and virtual histology (VH-IVUS).

The findings will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). Their findings are summarized in the abstract titled "Comparison of Intravascular Modalities for Detecting Vulnerable Plaque: Conventional Ultrasound vs. Virtual Histology vs. Optical Coherence Tomography."

Lead investigator So-Yeon Choi, M.D., Ph.D. said, "OCT may answer longstanding questions about the relationship between vulnerable plaque and the risk of heart attack."

To assess the ability of each imaging modality to detect the specific characteristics of vulnerable plaque, investigators performed IVUS, VH-IVUS and OCT in 48 patients who were categorized as having stable angina pectoris (15) or acute coronary syndromes (33). OCT easily detected vulnerable plaque, with two observers analyzing the images independently.

Dr. Choi noted that, "OCT detected most of the major and minor characteristics of vulnerable plaque, including the thin cap with large lipid core, and it has the ability to detect thrombus and fissured plaque at a level that is four to five times better than that of other modalities. Because of OCT's high resolution capabilities, which is almost 10 times greater than with IVUS and related modalities, it can assess this tissue more accurately than other imaging methods."

As a result, researchers said OCT may provide a better understanding of the natural progression of coronary artery disease. For example, stenosis or erosion of endothelial cells with plaque could be detected even in patients with stable angina.

"That finding is something that we had never experienced before; we should study more the clinical implication of these findings," Dr. Choi said. "New evolving OCT imaging is moving closer to becoming a powerful diagnostic tool that will provide new insights into the etiology and treatment of coronary artery disease."

The current OCT technology does have some limitations, though. It needs a blood-clear zone and a low penetrating depth to be most effective. However, the procedure is safe and can be performed in a cath lab.


Story Source:

The above story is based on materials provided by Cardiovascular Research Foundation. Note: Materials may be edited for content and length.


Cite This Page:

Cardiovascular Research Foundation. "Vulnerable Plaque May Be Easier To Detect Through New Imaging Technology." ScienceDaily. ScienceDaily, 15 October 2008. <www.sciencedaily.com/releases/2008/10/081012121322.htm>.
Cardiovascular Research Foundation. (2008, October 15). Vulnerable Plaque May Be Easier To Detect Through New Imaging Technology. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/10/081012121322.htm
Cardiovascular Research Foundation. "Vulnerable Plaque May Be Easier To Detect Through New Imaging Technology." ScienceDaily. www.sciencedaily.com/releases/2008/10/081012121322.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins